Entrepreneurship in Action, 21-24 Nov, online. Build a working product with AI

How Does a Patent Protect an Invention? | How It Works

12 min read

On this page

What is the short answer?

A patent is a bargain between an inventor and a state. The inventor publishes how the invention works. In return, the owner may stop others from making, using, selling or importing it for a limited time, generally 20 years from the filing date.

A patent is not automatic: the inventor must apply to a patent office, which examines the invention. Nor is it a right to use the invention, since other patents or laws may block that. And it works only where granted.

Definition: A patent is a legal right, granted by a national or regional office, to exclude others from making, using, selling or importing an invention for a limited term, in return for disclosing it clearly enough for a skilled person to carry it out.

What makes an invention patentable?

The World Trade Organization's TRIPS Agreement, in force since 1 January 1995, sets minimum rules. Article 27 says patents must be available "in all fields of technology" for inventions that are new, involve an inventive step and are capable of industrial application.

Under the European Patent Convention (EPC), novelty means the invention was not made public in any way before the filing date. An inventive step, called non-obviousness in the United States, means it would not be obvious to a skilled person. Industrial application, or utility, means it can be made or used in industry.

Laws also exclude some things. EPC Article 52 says discoveries, scientific theories, mathematical methods and computer programs are not inventions "as such", and Article 53 excludes methods of surgery, therapy and diagnosis practised on the body. Japan's Patent Act defines an invention as "the highly advanced creation of technical ideas utilizing the laws of nature".

Section 3(d) of India's Patents Act excludes a new form of a known substance unless it enhances the substance's known efficacy.

How does an application become a patent?

The inventor files a description and claims, numbered sentences setting out what the patent would cover. The first filing date becomes the priority date. Offices commonly publish an application about 18 months after that date, often before any decision; EPC Article 93 and US law both set this rule.

An examiner searches earlier patents and papers and applies the tests. Some offices examine only on request: in Japan, the request must come within three years of filing, or the application is deemed withdrawn. The office then grants or refuses it.

At the European Patent Office (EPO), anyone may then file an opposition within nine months of the grant being announced.

The owner must keep paying. UK renewal fees start on the fourth anniversary of filing, then fall due every year. US utility patents need maintenance fees 3½, 7½ and 11½ years after grant. TRIPS Article 33 says protection must not end before 20 years from filing.

Why does a patent stop at the border?

Patents are territorial: each country or region grants its own. Under the Paris Convention, concluded in 1883, patents for the same invention in different member states are independent.

The Convention also gives a right of priority. After a first filing in one member state, an applicant has 12 months to file in the others; those filings count as made on the first day.

The Patent Cooperation Treaty (PCT), concluded in 1970, lets one international application have effect in all 159 contracting states listed on WIPO's page on 9 November 2026. WIPO publishes it shortly after 18 months. In most states, the national phase must begin before the end of the 30th month from priority. National or regional offices still grant the patents.

After grant, a classic European patent from the EPO is kept alive by renewal fees paid to each country's national office. Since 1 June 2023, an owner may instead request a Unitary Patent, one right that, if registered now, covers 18 EU member states, with one yearly renewal fee paid to the EPO.

How is a patent enforced, and what limits it?

Offices grant patents; courts enforce them. The USPTO says it has no jurisdiction over infringement, so an owner sues in federal court. The claims set the boundary: under EPC Article 69, protection is "determined by the claims", read with the description.

A patent can be revoked. Under EPC Article 138, a court may revoke a European patent for a country if, for example, its subject matter is not patentable or it fails to disclose the invention clearly enough.

TRIPS Article 30 allows "limited exceptions". A WTO panel report adopted on 7 April 2000 found that Canada could let generic makers use a patented drug to seek approval before expiry, but not to stockpile it. India's law exempts use "merely of experiment or research".

Under TRIPS Article 31, a government may grant a compulsory licence, allowing use without the owner's consent; the owner receives "adequate remuneration". The Doha Declaration of 14 November 2001 confirmed each member's right to grant such licences and to decide the grounds.

What have courts decided about what can be patented?

  • United States, Diamond v. Chakrabarty (16 June 1980). By five votes to four, the Supreme Court held that "a live, human-made micro-organism is patentable subject matter": here, an engineered bacterium that breaks down crude oil.
  • United States, Alice Corp. v. CLS Bank (19 June 2014). The Court held unanimously that claims to settling financial trades through a third party were drawn to an abstract idea, and that a generic computer did not make them patentable.
  • India, Novartis v. Union of India (1 April 2013). The Supreme Court held that the beta crystalline form of the cancer medicine imatinib mesylate failed the tests of invention and of section 3(d). It added that section 3(d) does not bar all incremental inventions.
  • United Kingdom, Thaler (20 December 2023). Stephen Thaler named his AI system, DABUS, as inventor. The Supreme Court held that an inventor under the Patents Act 1977 "must be a natural person". On 5 August 2022, the US Court of Appeals for the Federal Circuit had held that US inventors must be human beings.

What do supporters and critics argue about patents?

  • Incentives and access to medicines. On 17 June 2022, WTO ministers agreed that, for five years, developing country members may authorise the use of patents needed to make and supply COVID-19 vaccines without the owner's consent, including for export. India and South Africa had proposed a wider waiver on 2 October 2020. Supporters of patent incentives, such as the industry body IFPMA, said that day the decision "sends the wrong message" to innovators, and that trade, not intellectual property, was the biggest factor in vaccine scarcity. Critics, such as Médecins Sans Frontières (MSF), said it essentially covered only vaccines, not treatments or tests, and would not ensure affordable access.
  • Patent thickets. Critics such as I-MAK use the term patent thicket for many overlapping patents on one medicine, and argue thickets delay competition; in a post of 9 October 2023, I-MAK said its study linked extended protection on four biologic drugs to limited biosimilar competition. Supporters of the current system, such as the US Chamber of Commerce on 1 July 2024, cite a USPTO and FDA study of June 2024 that called patent counts an imprecise measure.
  • AI as inventor. In its consultation response of 28 June 2022, the UK government said a few respondents argued naming AI as an inventor "would encourage innovation and investment in AI technology". Most said no legal change was the best option at the moment, and the government decided on no change for now.

How does this work with real numbers?

Both examples are illustrative; the rules come from the sources.

How long does each step take?

An inventor files first in Japan on 10 March of Year 1, the priority date. She files at the EPO, claiming that priority, on the last day of the priority year.

Table: Key dates for one invention (illustrative)

StepRuleDate
Priority year ends; European filingParis Convention, 12 months10 March, Year 2
Both applications published18 months from priority10 September, Year 2
PCT national phase, had she used the PCT30 months from priority10 September, Year 3
Japanese examination request due3 years from filing (Japan only)10 March, Year 4
Japanese patent ends20 years from Japanese filing10 March, Year 21
European patent ends20 years from European filing10 March, Year 22

Each term runs from that application's own filing date, so the European patent can last a year longer.

What does it cost to keep a patent alive, and what can it earn?

Suppose a country charges rising yearly renewal fees from Year 5 to Year 20.

Table: Illustrative renewal fees over one term

YearsFee each yearPaymentsSubtotal
5 to 8$1004$400
9 to 12$2504$1,000
13 to 16$4504$1,800
17 to 20$7004$2,800
Whole term16$6,000

The owner licenses the patent to a maker for a royalty of 3% of sales. Sales of 50,000 units a year at $40 make 50,000 × $40 = $2,000,000, so the royalty is 0.03 × $2,000,000 = $60,000 a year. The Year 17 fee is 700 ÷ 60,000 ≈ 1.2% of that.

If sales stop, the owner may stop paying and let the patent lapse; under US law, an unpaid fee ends it after a six-month grace period.

Where can the student go deeper in World 101?

This page follows one right from filing to expiry: how a patent is granted, what it lets its owner do and where it stops. The World 101 subject Intellectual Property & Copyright takes the wider view of how the law treats ideas as property, balancing reward for creators against others' freedom to build on their work.

Three related subjects go further. Entrepreneurship and New Ventures looks at how founders turn an idea into a business, where a patent may be one asset among many. Healthcare Systems & Access studies how people reach the medicines and care they need, the setting for the debate on drug patents. International Trade & Global Finance covers the trading system in which the TRIPS Agreement sits.

Sources

  • WTO, TRIPS Agreement, Articles 27 to 33, and overview (in force 1 January 1995), read 9 November 2026.
  • WTO, Doha Declaration, 14 November 2001; DS114 page (report adopted 7 April 2000).
  • WIPO, Paris Convention summary (1883); PCT summary (1970) and FAQs (updated August 2026), read 9 November 2026.
  • EPO, EPC Articles 52 to 57, 63, 69, 93, 99 and 138; Unitary Patent pages (launched 1 June 2023), read 9 November 2026.
  • 35 U.S.C. 41, 101, 122 and 154 (Cornell LII); USPTO, "Manage your patent", updated 20 October 2025.
  • GOV.UK, "Renew a patent", read 9 November 2026; AI and IP consultation response, 28 June 2022.
  • Japan, Patent Act (Act No. 121 of 1959), Japanese Law Translation, read 9 November 2026.
  • India, Patents Act, 1970 (Act No. 39 of 1970), sections 3(d) and 47(3), via Novartis and WIPO's flexibilities database, read 9 November 2026.
  • Supreme Court of India, Novartis AG v. Union of India, 1 April 2013 (Indian Kanoon).
  • US Supreme Court, Diamond v. Chakrabarty, 16 June 1980, and Alice Corp. v. CLS Bank International, 19 June 2014 (Cornell LII).
  • UK Supreme Court, Thaler v Comptroller-General, [2023] UKSC 49, 20 December 2023 (Patents Act 1977); Federal Circuit, Thaler v. Vidal, 5 August 2022 (BitLaw).
  • Congressional Research Service, R47231, 31 August 2022 (proposal of 2 October 2020; decision of 17 June 2022).
  • IFPMA and MSF statements, 17 June 2022.
  • I-MAK, 9 October 2023; National Law Review, 24 June 2024 (USPTO and FDA study); US Chamber of Commerce, 1 July 2024.

Common errors and misconceptions

  • Misconception: A patent gives its owner the right to make and sell the invention. Correct: It gives only a right to exclude others; using the invention may still depend on other patents and laws.
  • Misconception: There is a single worldwide patent. Correct: Patents are territorial; the PCT offers one international application, but national or regional offices grant patents.
  • Misconception: An invention is protected as soon as it is made. Correct: The inventor must apply, and an office must grant the patent first.
  • Misconception: Patent applications stay secret until grant. Correct: Most are published about 18 months after the earliest priority date, often before grant.
  • Misconception: Once granted, a patent lasts 20 years whatever happens. Correct: The owner must keep paying renewal or maintenance fees, and a court can revoke the patent.

Key takeaways

  • A patent is a bargain: the inventor discloses the invention, and the owner gains a time-limited right to stop others making, using, selling or importing it.
  • Under TRIPS Article 27, an invention must be new, involve an inventive step and be capable of industrial application, though laws exclude some subject matter.
  • An application is filed, usually published at about 18 months, examined, then granted or refused, and kept alive by renewal fees.
  • Patents are territorial; the Paris Convention's 12-month priority right and the PCT help an inventor seek protection in many countries.
  • Courts decide infringement by reading the claims, and can revoke a patent that should not have been granted.
  • Compulsory licences under TRIPS Article 31, confirmed by the Doha Declaration of 2001, let governments allow use without the owner's consent.

Test yourself

What does a patent owner give in return for the right to exclude?

The owner discloses the invention clearly and completely enough for a skilled person to carry it out.

What are the three usual tests of patentability?

Novelty, an inventive step (non-obviousness in the United States) and industrial application, sometimes called utility.

In the timeline example, why does the European patent end a year after the Japanese one?

Each term runs 20 years from that application's own filing date, and the European application was filed 12 months later.

In the cost example, how is the $60,000 royalty found?

Sales of 50,000 units at $40 make $2,000,000 a year, and 3% of that is $60,000.

What did the US Supreme Court decide in Diamond v. Chakrabarty?

It held that a live, human-made micro-organism, a bacterium that breaks down crude oil, is patentable subject matter.

Why could DABUS not be named as an inventor in the United Kingdom?

The UK Supreme Court held that an inventor under the Patents Act 1977 must be a natural person.

Write about it

Turn a question from this chapter into a paper.

The Writing Studio has a structure guide, a rubric and citation tools for 15 formats, from essays to research papers. A free account keeps up to five drafts. Learnacy Essential adds feedback from an AI writing coach and submission to The OYI Review.

Publication depends on review and is not guaranteed.